Background {#Sec1}
==========

Non-communicable diseases (NCDs), especially cardiovascular diseases (CVD; coronary artery, cerebro-vascular, and peripheral vascular diseases) are a leading cause of mortality among middle aged and older adults in India \[[@CR1]\]. Prevalence of CVD risk factors (smoking, hypertension, diabetes mellitus, obesity, dyslipidemia, unhealthy diet, and reduced physical activity) is increasing, and recent studies report up to 40 % of Indian adults to be hypertensive \[[@CR2]\], and 10 % to be diabetic \[[@CR3]\]. Risk factor control requires a multidisciplinary approach, which includes approaching social determinants of health, health-care financing, improving medical education, and health system strengthening to better manage risk factors \[[@CR4]\]. Except for smoking and low vegetable and fruit diet, most of the risk factors for CVD are more prevalent in high socioeconomic groups \[[@CR5]\]. However considering large proportion of population in lower socioeconomic group, it has been suggested that most of the burden of risk factors is contributed by poor and underprivileged \[[@CR6]\], which puts higher onus on public health delivery system for NCD care in India.

Government of India has responded to the increasing burden of NCDs through launch of a National Program for Prevention & Control of Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) in 2008 \[[@CR7]\]. Currently in its second phase, the program includes 100 of 640 districts (15.6 %) in India. The NPCDCS aims at integration of NCD interventions in the overall public-health delivery framework for optimization of scarce resources and provision of seamless services to patients as also for ensuring long term sustainability of interventions \[[@CR7]\]. WHO developed a global monitoring framework to enable global tracking of progress in preventing and controlling major non-communicable diseases - cardiovascular disease, cancer, chronic lung diseases & diabetes and their key risk factors. Targets and indicators for availability of essential non-communicable disease medicines and basic technologies to treat major non-communicable diseases have been described under national systems response category. An 80 % availability of the affordable basic technologies and essential medicines, including generics, required to treat major non-communicable diseases in both public and private facilities is expected to be achieved by 2025. In this context Government of Madhya Pradesh has launched free drug distribution and laboratory investigation scheme in public health facilities. While this is a work in progress, and the program is likely to be scaled up to all the districts of the country, it is important to understand existing infrastructure and readiness of public health infrastructure for NCD care.

Public health delivery system in rural India consists of Primary Health Centers (PHC; n \~ 25,000; catchment population \~30,000) as a level 1 facility, and a Community Health Center (CHC; n \~ 5000; catchment population \~ 100,000) a level 2 facility. CHC functions as a level 1 facility for the village it is located-in, and level 2 facility for the villages catered by adjoining PHCs in the catchment area. Together, these facilities are designed to meet most primary care needs through medical doctors, paramedical staff, basic investigations and essential drugs \[[@CR8]\]. Over the years, focus of primary care in India has been communicable diseases, and reproductive and child health services. As a consequence, it is likely that some key facility-based elements required for NCD-care may be lacking. The current study was performed to understand availability of health-facility level infrastructure for delivery of CVD care in PHCs and CHCs in state of Madhya Pradesh.

Methods {#Sec2}
=======

Setting {#Sec3}
-------

Madhya Pradesh is second largest state in India by area, and sixth by population (population \~ 72 million (2011 census)) and has network of 1157 PHCs and 334 CHCs \[[@CR9]\]. Between May and August 2013, Department of Public Health and Family Welfare, Government of Madhya Pradesh, and All India Institute of Medical Sciences Bhopal conducted workshops for medical officers posted in PHCs and CHCs of the state. Purpose of these workshops was to upgrade skills with regards to identification and management of hypertension, diabetes and CVD risk factors. Request for nomination for these workshops were sent by Directorate Health Services to Chief Medical Officers of 24 districts. These districts have a network of 169 CHCs and 640 PHCs. Nominations of 66 and 56 medical officers of PHCs and CHCs were received of which 48 and 39 attended the workshops respectively. These Medical officers belonged to five districts where NPCDCS has been launched in the state (Chindwara, Dhar, Hoshangabad, Jhabua and Ratlam) and another nineteen districts (Balaghat, Betul, Bhind, Bhopal, Dindori, Gwalior, Khandwa, Khargone, Mandsaur, Morena, Raisen, Satna, Sehore, Seoni, Shahdol, Shajapur, Shivpuri, Sidhi, and Ujjain). We performed a questionnaire-based survey to understand facility level infrastructure in the State.

Participants {#Sec4}
------------

A total of 85 (97.7 %) Medical officers (38 from CHC and 47 from PHCs) participated in the survey and provided facility level information. Workshop was conducted in batches, with a maximum batch size of 20. A total of five workshops were conducted, and questionnaire was administered at the start of each workshop, and participation was voluntary. In order to ensure a correct reporting, and to protect participants from potential administrative repercussions on reporting of deficiencies in the system, we decided not to collect any personal identifiers (Name of respondent, or the facility) for this study. Hence we requested Institutional Human Ethics Committee (IHEC) of AIIMS Bhopal for a waiver of consent. This request and the study design were approved by the IHEC of AIIMS Bhopal.

Procedure {#Sec5}
---------

We designed a facility assessment questionnaire based on Indian Public Health Standards (IPHS) for PHC and CHC \[[@CR10]\], and World Health Organization package of essential NCD interventions (WHO PEN) guidelines \[[@CR11]\]. We initially consulted core team of medical and public health specialists (who were also involved in the designing training curriculum for the medical officers), to draw up a list of tools and technologies required for primary care management of key NCDs. Items in this list that were also included in either WHO-PEN or IPHS were retained. World Health Organization has proposed a package of essential NCD interventions (WHO PEN) for low resource settings \[[@CR11]\]. This package lists simple technologies that must be available, and others to be added when resources permit. While WHO-PEN provides for a list of essential technologies and drugs required in primary care, it neither details human resource requirements, nor does it discriminate between levels of Primary care. IPHS has separate standards for PHC & CHC, including human resources, infrastructure, equipment & drugs, but does not have a NCD focus. We took most items from the PEN and relevant items from IPHS standards in the current study. The complete set of expanded questionnaire with source of individual items is presented in Table [1](#Tab1){ref-type="table"}. We divided all the items of the questionnaire in five domains (Human resources, equipment, point-of-care supplies, laboratory based tests and drugs), and for two disease conditions (hypertension and diabetes). We included four basic drugs needed in management of hypertension (Angiotensinin Converting Enzyme Inhibitors (ACEI)/ Angiotensin receptor blockers (ARB), Beta blockers, Calcium channel blockers, (CCB) and Thiazide diuretics) and four drugs commonly used in management of diabetes mellitus (Metformin, Glibenclamide, Glimiperide, and Insulin) in the questionnaire. In each domain, we provided a list of facilities, and expected answer was to be either Yes or No or do-not know (coded as 1, 0 and 99 respectively). We grouped key facilities as needed in management of diabetes and hypertension to understand preparedness for their management in public health system. There were two versions of the questionnaire; first version with 15 items was administered to 48 medical officers. We expanded the questionnaire in later part of the study, largely to assess for availability of essential drugs and medications pertaining to NCDs. The final version was expanded to include 36 items, which was administered to 37 medical officers who reported in remaining batches.Table 1Domains, sub-groups and key items evaluated in the questionnaireDomainSub-groupKey items evaluatedSource of itemHuman resourceTwo Medical OfficersIPHS-PHC & CHCLaboratory technicianIPHS-PHC & CHCHealth EducatorIPHS-PHC & CHCNutritionistIPHS-CHC (Dietician)PhysiotherapistIPHS-CHC (Rehabilitation worker)EquipmentEquipment for diagnosis of hypertensionSphygmomanometer (Mercury or Aneroid)^a^IPHS-PHC & CHC,PENEquipment for diagnosis of diabetesGlucometer^b^PENEquipment for evaluation of neuropathyPercussion Hammer or Tuning forkIPHS-PHC & CHC,PEN (Only tuning fork)Equipment for assessment of abdominal obesityMeasuring tapePENEquipment to measure body mass index (BMI)Stadiometer and weight machineIPHS-PHC & CHC, PEN (Only weight machine)Equipment to evaluate cardiac complicationECG machine^a^IPHS-CHC, PENPoint-of-care testing suppliesGlucose testing stripsPENLancets/needle for finger-prickPENUrinary strip for Ketones^b^PENUrinary strip for Proteins^ba^PENLaboratory servicePlasma Glucose estimation^b^PENSerum creatinine^ba^IPHS-CHC, PENSerum lipid profileIPHS-CHC, PENHbA1C estimationNoneDrugsDrug useful for long term management of Hypertension and Lipid lowering drugs^a^ACEI/ARB (Enalapril, Ramipril, Losartan etc.)IPHS-PHC & CHC, PENBeta blocker (Atenolol)IPHS-PHC & CHC, PENCCB (Amlodepine)IPHS-PHC & CHC, PENDiuretic (Thiazide)IPHS-PHC & CHC, PENLipid lowering (Atorvastatin)IPHS-PHC & CHC, PENDrug useful for long term management of Diabetes MellitusL^b^MetforminIPHS-PHC & CHC, PENGlibenclamideIPHS-PHC & CHC, PENGlimepirideIPHS-PHC & CHC, PENPioglitazoneIPHS-PHC & CHC, PENInsulin (any)IPHS-PHC & CHC, PENDrugs used in management of chronic disease emergencies and Dexamethasone, which is frequently misusedAspirin low doseIPHS-PHC & CHC, PENNitrate (Sorbitrate)IPHS-PHC & CHC, PENNifedepineIPHS-PHC & CHC, PENFrusemideIPHS-PHC & CHC, PENDexamethasoneIPHS-PHC & CHC^a^These facilities are key for primary care management of hypertension^b^These facilities are key for primary care management of diabetes mellitus*IPHS* Indian Public Health Standards (for *PHC* (Primary health centers 2012) or *CHC* (Community health centers 2012)), *PEN* Package of essential non-communicable disease interventions for primary care

Statistical analysis {#Sec6}
--------------------

We performed descriptive analysis for the collected data and analyzed frequencies separately for community health centers (a facility with higher level of functionality) and primary health centers (a facility with a lower level of functionality). We averaged proportions for individual items under a domain, to indicate coverage in a particular domain. For instance, to indicate overall drug availability, we averaged proportions of all drug classes included in the survey. To estimate readiness for individual diseases such as hypertension or diabetes mellitus, we used disease-specific indicators in point-of-care tests, laboratory tests, and drug domains. Statistical analysis was performed in Microsoft Excel version 2010.

Results {#Sec7}
=======

Overall availability of facilities was lowest in the domains of laboratory services and human resource. Availability of all drug classes required for management of diabetes, hypertension and their acute complications was intermediate. Equipment and point of care supplies had better availability (Fig. [1](#Fig1){ref-type="fig"}). Availability of various facilities amongst CHCs of districts where NPCDCS is being piloted (*n* = 14) and other districts (*n* = 25) was similar.Fig. 1Radar diagram depicting average availability of facilities for all indicators in five domains (Human resource, Equipment, Laboratory service, Point-of-care supplies and Drugs). CHC- Community Health Centre; PHC- Primary Health Centre

In Human resource domain, while two medical officers were available in most CHCs, this was the case in less than half PHCs sampled. Similarly availability of Laboratory technicians and Health Educators was also significantly lower. Nutritionists and physiotherapists were mostly not available at either level of care (Table [2](#Tab2){ref-type="table"}). In equipment domain, sphygmomanometer was available at all PHCs and CHCs, measuring tape was available in about 80 % of facilities, and height measurement equipment was available in about half of all facilities. Glucometer was available in most CHCs, but in less than half of the PHCs. ECG machine was available in only about one-third of CHCs, and less than 10 % of PHCs (Table [2](#Tab2){ref-type="table"}). While point of care test supplies (blood glucose estimation strips/glucostrips, needles, urinary protein strips etc.) were available in most CHCs, their availability was significantly lower in PHCs. Availability of urinary ketone strip, useful for diagnosis of diabetes related complication, was available in only half of all CHCs, and a third of all PHCs. Availability of laboratory based tests was negligible at PHCs, and low at CHCs (Table [2](#Tab2){ref-type="table"}).Table 2Availability of key items in community health centers and primary health centersCommunity health centerPrimary health centerGroupVariableAvailableTotalPercentAvailableTotalPercentVariables assessed in full version of questionnaire (*n* = 85)Human resourceLaboratory technician353892.11124725.53Health Educator173844.74104721.28EquipmentGlucometer323884.21204742.55Sphygmomanometer3838100.004747100.00ECG machine133834.2154710.64Measuring tape303878.95384780.85Stadiometer and Weight machine233860.53234748.94Point-of-care testing suppliesGlucostrips333886.84244751.06Lancets/needle353892.11344772.34Urinary ketone strip223857.89174736.17Urinary protein strip313881.58274757.45Laboratory testPlasma Glucose estimation293876.32134727.66Serum creatinine173844.744478.51Serum lipid profile103826.324478.51HbA1C2385.262474.26Additional variables assessed in second version of questionnaire (*n* = 37)Human resourceTwo Medical Officers101283.33112544.00Nutritionist21216.670250.00Physiotherapist1128.330250.00EquipmentPercussion hammer/tuning fork61250.00122548.00DrugsAny anti-hypertensive1212100.00222491.67ACEI/ARB61250.0072528.00Beta blocker1212100.00172568.00Calcium channel blocker (CCB)111291.67212584.00Diuretic Thiazide41233.3342516.00Atorvastatin21216.6742516.00Any anti-diabetic drug111291.67172568.00Metformin101283.33172568.00Glibenclamide21216.6742516.00Glimepiride21216.6752520.00Pioglitazone1128.332258.00Insulin51241.6732512.00Aspirin low dose61250.00112544.00Frusemide101283.33192576.00Sorbitrate91275.00122548.00Nifedepine101283.33172568.00Dexamethasone111291.67232592.00

Among facilities for primary care management of hypertension, equipment for diagnosis and at least one anti-hypertensive drug was available at most PHCs and CHCs. In contrast, facility to screen for diabetes mellitus with help of glucometer was reported to be not available at more than half of PHCs and about a fifth of all CHCs. Availability of supplies or services to screen for complications related to these conditions was much lower (Table [2](#Tab2){ref-type="table"}). Availability of drugs used in long-term treatment of hypertension, diabetes mellitus, and their acute complications was enquired from a subset of medical officers. Two of the four basic drugs needed in management of hypertension (beta-blockers and calcium channel blockers) were available at most PHCs and CHCs. One of four drugs for management of diabetes mellitus (metformin) was available at most CHCs and about two-thirds of all PHCs. Other drugs used in management of diabetes mellitus (other oral drugs and insulin) were largely unavailable (Table [2](#Tab2){ref-type="table"}).

Low dose aspirin, which is most useful and inexpensive of all cardiovascular drugs was available at about half of all facilities. Lipid lowering drugs were available in less than one-sixth of all facilities. Nitrates were available at about three-fourths of all CHCs, and less than half of all PHCs. On the contrary, dexamethasone, a drug which is frequently misused in emergency management of cardiovascular complications was available at most PHCs and CHCs.

Discussion {#Sec8}
==========

Current facility assessment study shows critical gaps in key items required for management of NCDs at primary care level. Human resource and laboratory services need to be strengthened the most, followed by sustained availability of all required drug classes, equipment and related supplies, and upgrading point-of-care testing. There are larger gaps in PHCs, which are level 1 facilities, as compared to CHCs, which are level 2 facilities in primary-care.

In order to achieve Universal health-care, there is a need to strengthen primary-care delivery in India. Deficiencies in human resources and laboratory services assessed as part of this study impact a wide range of health services beyond CVDs. While we have strengthened a wide range of specific services in primary-care in India (such as immunization coverage \[[@CR12]\], availability of contraceptives \[[@CR13]\], treatment of tuberculosis \[[@CR14]\], institutionalized child-births \[[@CR15]\]). As it is expected that 70 % of the health budget needs to be earmarked for primary health care under universal health coverage \[[@CR16]\], we need to understand chain of CVD care resources (human resource, drugs, and health technology (equipment and laboratory services) that needs to be optimized to specifically improve CVD coverage in India.

First component in this chain are human resources. Management of CVDs like hypertension and diabetes requires life-long behavioral change which needs to be implemented using trained human resources. A PHC provides coverage to at least 30,000 population of which approximately 18,000 would be having age more than 15 years, which could mean about 3600 adults with hypertension, and about 600 with diabetes mellitus considering prevalence of hypertension and diabetes to be 20 and 3.3 % respectively. Even if a third of them were to seek care in the PHCs, medical doctors alone will never be sufficient to meet all the CVD-care needs. A medical doctor is considered necessary for first diagnosis and subsequent follow-ups, various task-components need to be shifted to supervised non-physician health workers. For instance, screening for hypertension and diabetes mellitus using blood pressure equipment or glucometers can be done with help of trained health-workers \[[@CR17]\]. All individuals with hypertension and diabetes need intensive health education, meaningful dietary advice, and physical activity advice, reinforced at every follow up visit. This can be achieved by training existing multi-purpose community health workers, as it will not be feasible to employ dedicated nutritionists and physiotherapists.

Second component in CVD-care chain are drugs. Drug therapy in CVD is complex due to multiple drug categories, and multiple drugs in each category. More recent disease manegement guidelines have simplified drug therapy protocols. Core list of medicines in WHO PEN, required for implementing essential NCD interventions includes four anti-hypertensives (ACEI, beta-blockers, CCBs, and thaizide diuretic), three anti-diabetics (metformin, glibenclamide, insulin), aspirin, nitrates, frusemide and a lipid-lowering drug. Current study shows discordance in availability of recommended class drugs. For example, for hypertension beta blockers and CCBs are widely available but ACEI or Thiazide diuretcics are not. Further, we found that availability of Aspirin and Lipid lowering drugs was low, despite both of these drugs being useful in prevention of vascular events in individuals who have diabetes mellitus (primary prevention) or in those who already have had a previous event (secondary prevention). This indicates lack of standard protocols, poor convergence and patchy coordination between service providers and health system managers. This could be rectified by consultative group meeting of experts on subject including service providers. It also calls for revision in the essential drug lists of the State to keep pace with the changing guidelines in management of CVDs.

Third component in CVD-care chain is technology, which includes simple essential tools, and more complex laboratory support. List of simple essential tools in WHO PEN include a blood pressure measurement device, measuring tape, weighing machine, glucometer, urinary protein and ketone testing strips. Except for blood pressure measurement device, these simple technologies were deficient in many primary-care facilities of Madhya Pradesh. Additional complex technologies to be added when resources permit include facility to measure serum creatinine, lipids, and electrocardiography that were mostly not available. Average availability of these necessary drugs and technologies reported in the enrolled health-centers ranged between 11 and 55 % in PHCs, and 37 and 80 % in CHCs.

A similar study was done by Mendis et al. \[[@CR18]\] in 90 facilities across eight low-and-middle-income countries, which reported similar deficiencies in human resources, drugs and technologies. Major deficits were identified in health financing, access to basic technologies and medicines, medical information systems, and the health workforce \[[@CR18]\]. The growing burden of CVDs needs to be countered by strengthening primary care facilities, especially for hypertension and diabetes \[[@CR19]\].

In current study, we were able to perform facility assessment with minimal resources, and in a short period of time. Since it was conducted by means of questionnaire administration, directed towards workshop participants, it has some inherent limitations. First limitation is selection bias as primary health centers were conveniently sampled based on medical officers posted in these PHCs who attended the workshop. This bias is likely to oversample those PHCs which have better facilities, as centers which did not have a medical officer to spare at the time will not be sampled. PHCs with such human resource deficit are more likely to lack in facilities. Despite this limitation our study samples facilities from half of all districts, and covers entire geographic spread of Madhya Pradesh. Second limitation is information bias, as we did not perform onsite assessment, and responses were not verifiable and therefore functionality of equipment could not be commented. However, we believe that medical officers, are more likely to over-report availability of certain key items. This is especially true about perishable items such as drugs. Last is measurement bias, as questionnaire based surveys such as ours report facilities which are generally present, rather than those present on a particular day or time. This bias is also likely to be away from null, and over-report availability of facilities. Despite these limitations, which are all operationally away from null, we report critical gaps in infrastructure which need to be addressed to make NCD control successful in public health facilities focused towards primary care.

Conclusions {#Sec9}
===========

Preparedness for comprehensive care from prevention, early diagnosis to treatment and complication management of NCDs at primary care level is sub-optimal due to critical gaps in health facilities of Madhya Pradesh. These gaps highlight need for strengthening of primary health care systems for scaling up of interventions for prevention and management of chronic diseases so as to achieve goal of universal coverage and reduce the burden of NCDs.
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